U.S. has highest first-day infant mortality out of

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28 Lmcat #61869
291
U.S. has highest first-day infant mortality out of industrialized world, group reports

And this is before post birth abortions(murder) is factored in. Is this more population control?

https://www.cbsnews.com/news/us-has-highest-f...p-reports/

A new report reveals that the United States has the highest first-day infant death rate out of all the industrialized countries in the world.

About 11,300 newborns die within 24 hours of their birth in the U.S. each year, 50 percent more first-day deaths than all other industrialized countries combined, the report's authors stated.

The 14th annual State of the World's Mothers report, put together by non-profit organization Save the Children, ranked 168 countries according to where the best places to be a mother would be. Criteria included child mortality, maternal mortality, the economic status of women, educational achievement and political representation of women.

Worldwide, the report found that 800 women die each day during pregnancy or childbirth, and 8,000 newborns die during the first month of life. Newborn deaths make up 43 percent of all deaths for children under five. Sixty percent of infant deaths occur during the first month of life.

The top five countries to be a mom were Finland, Sweden, Norway, Iceland and the Netherlands. The bottom five were Niger, Mali, Sierra Leone, Somalia and the Democratic Republic of the Congo.

Because of their high infant mortality rates, the U.S. only ranked number 30 this year on the report, down five spots from the 2012 report. Save the Children CEO Carolyn Miles told CBSNews.com she was shocked to find that out that the U.S. did so poorly.

"We do not do as well on many of those as the Scandinavian countries," Miles admitted.

The 2013 edition focused on newborn mortality rates on the first day. The report's authors stated that the first 24 hours of a child's life are the riskiest.

More than 1 million babies worldwide die during their first day -- even though there are low-cost technology interventions that can save the lives of 75 percent of those children, Miles pointed out.

Simple measures like using a hand-pumped mask that can help resuscitate newborn infants who aren't born breathing only costs $5 a day. Also, making sure that mothers have access to simple antibiotics -- which costs about $2 a shot -- can save up to 500,000 of those babies.

"Antibiotics are very simple and very low tech. It doesn't take a doctor to administer an antibiotic injection. It can be administered by a nurse," Miles said.

The problem in the U.S. is that many of the babies born here are premature. Miles said that means that most women, especially poor mothers, aren't getting enough access to medical care.

"We need to make sure particularly poor mothers get access to quality prenatal care and actually go to the doctor and go to the doctor on a regular basis," she said.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 22

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 22

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Claigan Webinar Tackles Prop 65 Warnings for 2028

Updated Category News Views 26

Buckle up, folks. Here comes a wake-up call for businesses playing loose with their compliance homework on California's Prop 65, thanks to Claigan's latest announcement. They're hosting a webinar on October 7, 2026, gearing up everyone who'll listen for the changes hitting the books in 2028. We’re zooming past the days of generic warnings; pretty soon, it'll be all...

Continue Reading
Understanding Voting Rights and Corporate Governance at Valeo

Updated Category News Views 54

Understanding Voting Rights and Corporate Governance at Valeo Valeo, a prominent name in the mobility technology sector, plays an essential role in implementing innovative solutions that contribute to cleaner, safer, and smarter transportation. As a technology partner to automakers and emerging players in the mobility space, the company's advancements are vital for the...

Continue Reading
Transforming Field Service Management Through Strategic Alliances

Updated Category News Views 101

ServicePower and Marcone Appliance Parts Form Strategic Alliance In a notable development, ServicePower, a recognized leader in field service management software, has announced a strategic partnership with Marcone Appliance Parts, a well-established distributor in North America. This collaboration aims to revolutionize how service providers operate by integrating...

Continue Reading
Goldman Sachs Pushes Gold Price Target to Mid-2026

Updated Category News Views 639

Goldman Sachs Updates Gold Price Forecast Goldman Sachs has recently adjusted its predictions on gold prices, extending the expected timeline for reaching $3,000 per ounce to mid-2026. This update signals a significant shift from earlier forecasts that anticipated this milestone as early as December 2025. Factors Influencing the Price Revision The primary reason for this...

Continue Reading
Comcast's Generous $50,000 Donation for Storm Relief Efforts

Updated Category News Views 213

Comcast's Commitment to Community Support Comcast has recently made a poignant statement of support by donating $50,000 to assist nonprofit organizations as they work to aid those affected by destructive storms. This financially targeted initiative is designed to ensure families and businesses get the vital resources they require during challenging times. Donation Purpose...

Continue Reading